Copyright Reports & Markets. All rights reserved.

Global Microneedle Flu Vaccine Market Research Report 2021

Request for Sample of this report
Buy now

1 Microneedle Flu Vaccine Market Overview

  • 1.1 Product Overview and Scope of Microneedle Flu Vaccine
  • 1.2 Microneedle Flu Vaccine Segment by Type
    • 1.2.1 Global Microneedle Flu Vaccine Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Solid Microneedle
    • 1.2.3 Hollow Microneedle
    • 1.2.4 Coated Microneedle
    • 1.2.5 Dissolving Microneedle
  • 1.3 Microneedle Flu Vaccine Segment by Application
    • 1.3.1 Global Microneedle Flu Vaccine Sales Comparison by Application: (2021-2027)
    • 1.3.2 Influenza A
    • 1.3.3 Influenza B
  • 1.4 Global Microneedle Flu Vaccine Market Size Estimates and Forecasts
    • 1.4.1 Global Microneedle Flu Vaccine Revenue 2016-2027
    • 1.4.2 Global Microneedle Flu Vaccine Sales 2016-2027
    • 1.4.3 Microneedle Flu Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Microneedle Flu Vaccine Market Competition by Manufacturers

  • 2.1 Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Microneedle Flu Vaccine Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Microneedle Flu Vaccine Manufacturing Sites, Area Served, Product Type
  • 2.5 Microneedle Flu Vaccine Market Competitive Situation and Trends
    • 2.5.1 Microneedle Flu Vaccine Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Microneedle Flu Vaccine Players Market Share by Revenue
    • 2.5.3 Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Microneedle Flu Vaccine Retrospective Market Scenario by Region

  • 3.1 Global Microneedle Flu Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Microneedle Flu Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Microneedle Flu Vaccine Market Facts & Figures by Country
    • 3.3.1 North America Microneedle Flu Vaccine Sales by Country
    • 3.3.2 North America Microneedle Flu Vaccine Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Microneedle Flu Vaccine Market Facts & Figures by Country
    • 3.4.1 Europe Microneedle Flu Vaccine Sales by Country
    • 3.4.2 Europe Microneedle Flu Vaccine Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Microneedle Flu Vaccine Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Microneedle Flu Vaccine Sales by Region
    • 3.5.2 Asia Pacific Microneedle Flu Vaccine Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Microneedle Flu Vaccine Market Facts & Figures by Country
    • 3.6.1 Latin America Microneedle Flu Vaccine Sales by Country
    • 3.6.2 Latin America Microneedle Flu Vaccine Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Microneedle Flu Vaccine Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Microneedle Flu Vaccine Sales by Country
    • 3.7.2 Middle East and Africa Microneedle Flu Vaccine Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Microneedle Flu Vaccine Historic Market Analysis by Type

  • 4.1 Global Microneedle Flu Vaccine Sales Market Share by Type (2016-2021)
  • 4.2 Global Microneedle Flu Vaccine Revenue Market Share by Type (2016-2021)
  • 4.3 Global Microneedle Flu Vaccine Price by Type (2016-2021)

5 Global Microneedle Flu Vaccine Historic Market Analysis by Application

  • 5.1 Global Microneedle Flu Vaccine Sales Market Share by Application (2016-2021)
  • 5.2 Global Microneedle Flu Vaccine Revenue Market Share by Application (2016-2021)
  • 5.3 Global Microneedle Flu Vaccine Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Sanofi
    • 6.1.1 Sanofi Corporation Information
    • 6.1.2 Sanofi Description and Business Overview
    • 6.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Sanofi Microneedle Flu Vaccine Product Portfolio
    • 6.1.5 Sanofi Recent Developments/Updates
  • 6.2 GC Pharma
    • 6.2.1 GC Pharma Corporation Information
    • 6.2.2 GC Pharma Description and Business Overview
    • 6.2.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 GC Pharma Microneedle Flu Vaccine Product Portfolio
    • 6.2.5 GC Pharma Recent Developments/Updates
  • 6.3 Debiotech
    • 6.3.1 Debiotech Corporation Information
    • 6.3.2 Debiotech Description and Business Overview
    • 6.3.3 Debiotech Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Debiotech Microneedle Flu Vaccine Product Portfolio
    • 6.3.5 Debiotech Recent Developments/Updates
  • 6.4 NanoPass Technologies
    • 6.4.1 NanoPass Technologies Corporation Information
    • 6.4.2 NanoPass Technologies Description and Business Overview
    • 6.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio
    • 6.4.5 NanoPass Technologies Recent Developments/Updates
  • 6.5 Corium International
    • 6.5.1 Corium International Corporation Information
    • 6.5.2 Corium International Description and Business Overview
    • 6.5.3 Corium International Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Corium International Microneedle Flu Vaccine Product Portfolio
    • 6.5.5 Corium International Recent Developments/Updates
  • 6.6 Becton Dickinson and Company
    • 6.6.1 Becton Dickinson and Company Corporation Information
    • 6.6.2 Becton Dickinson and Company Description and Business Overview
    • 6.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio
    • 6.6.5 Becton Dickinson and Company Recent Developments/Updates
  • 6.7 FluGen
    • 6.6.1 FluGen Corporation Information
    • 6.6.2 FluGen Description and Business Overview
    • 6.6.3 FluGen Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 FluGen Microneedle Flu Vaccine Product Portfolio
    • 6.7.5 FluGen Recent Developments/Updates
  • 6.8 CosMED Pharmaceuticals
    • 6.8.1 CosMED Pharmaceuticals Corporation Information
    • 6.8.2 CosMED Pharmaceuticals Description and Business Overview
    • 6.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio
    • 6.8.5 CosMED Pharmaceuticals Recent Developments/Updates
  • 6.9 Microdermics and OraSure Technologies
    • 6.9.1 Microdermics and OraSure Technologies Corporation Information
    • 6.9.2 Microdermics and OraSure Technologies Description and Business Overview
    • 6.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio
    • 6.9.5 Microdermics and OraSure Technologies Recent Developments/Updates

7 Microneedle Flu Vaccine Manufacturing Cost Analysis

  • 7.1 Microneedle Flu Vaccine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Microneedle Flu Vaccine
  • 7.4 Microneedle Flu Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Microneedle Flu Vaccine Distributors List
  • 8.3 Microneedle Flu Vaccine Customers

9 Microneedle Flu Vaccine Market Dynamics

  • 9.1 Microneedle Flu Vaccine Industry Trends
  • 9.2 Microneedle Flu Vaccine Growth Drivers
  • 9.3 Microneedle Flu Vaccine Market Challenges
  • 9.4 Microneedle Flu Vaccine Market Restraints

10 Global Market Forecast

  • 10.1 Microneedle Flu Vaccine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Microneedle Flu Vaccine by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Microneedle Flu Vaccine by Type (2022-2027)
  • 10.2 Microneedle Flu Vaccine Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Microneedle Flu Vaccine by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Microneedle Flu Vaccine by Application (2022-2027)
  • 10.3 Microneedle Flu Vaccine Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Microneedle Flu Vaccine by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Microneedle Flu Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Solid Microneedle
    Hollow Microneedle
    Coated Microneedle
    Dissolving Microneedle

    Segment by Application
    Influenza A
    Influenza B

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Sanofi
    GC Pharma
    Debiotech
    NanoPass Technologies
    Corium International
    Becton Dickinson and Company
    FluGen
    CosMED Pharmaceuticals
    Microdermics and OraSure Technologies

    Buy now